Luminopia
Pioneering a new class of treatments for significant neuro-visual disorders.
Launch date
Employees
Market cap
-
Enterprise valuation
€58—87m (Dealroom.co estimates Jun 2023.)
Cambridge Massachusetts (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Grant | ||
N/A | $11.1m | Early VC | |
$12.0m | Early VC | ||
* | $5.7m Valuation: $60.0m | Seed | |
* | $16.0m | Series A | |
Total Funding | €40.7m |
Related Content
Recent News about Luminopia
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.